Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 5,876 shares at $20.00 ($118K) on 2018-03-19, disclosed to the SEC on 2018-03-20.
Open-market sale of $118k SNNA by Head of Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |